Cristian Luput - Feb 16, 2023 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Cristian Luput
Stock symbol
MAIA
Transactions as of
Feb 16, 2023
Transactions value $
$569
Form type
4
Date filed
2/21/2023, 05:54 AM
Previous filing
Feb 16, 2023
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $247 +58 +0.02% $4.25 279K Feb 16, 2023 Direct F1
transaction MAIA Common Stock Purchase $322 +76 +0.03% $4.24 279K Feb 17, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Luput that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchanage Act of 1934, as amended.
F2 The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.23 to $4.25, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.